packageTrametinib

trametinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Trametinib is a MEK inhibitor anticancer drug used to treat melanoma, including metastatic melanoma, and also studied for other cancers such as non-small-cell lung carcinoma and low-grade serous carcinoma. It is authorised in the European Union, where it is used for melanoma and glioma.

Summary written by glm-5.3-flash from Wikidata Q7833138 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:trametinib
ATC codes:L01EE01
DrugBank:DB08911
PubChem CID:11707110
ChEBI:75998
Wikidata:Q7833138
formula:C26H23FIN5O4
molar mass:615.399 g/mol (PubChem CID 11707110)
logP:3.4 (Drugs.Common 25.09, not verified)

Metabolites

HydroxyDabrafenibhydroxy-dabrafenib535.559 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
HydroxyDabrafenibmetabolite: hydroxy-dabrafenib